Symposiums

EMJ conducted interviews with two key opinion leaders and specialists in the prevention and treatment of cancer-related venous…

CKD-aP necessitates a differential diagnosis to ascertain that the itching a patient is experiencing is related to…

The last decade has seen a sharp increase in the number of freeze-all cycles and subsequent FETs. Annalisa Racca outlined the…

Here the speakers present highlights of a virtual satellite symposium at the 7th Congress of the European Academy of Neurology…

Chronic kidney disease can result in morbidity and mortality not only due to renal dysfunction itself, but also to associated…

Imlifidase was granted a conditional marketing authorisation by the European Commission in August 2020 for “desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor.”36 This milestone launched a new era in kidney transplantation for selected patients who would previously have remained untreated.

This symposium was developed to consider the future role that AI might play in the management of rheumatic diseases. First, Ignacio Medrano considered the current use of AI in healthcare and its possible future applications.

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an umbrella term for a group of rare, multisystem autoimmune…